AnalystsDavid NierengartenDavid Nierengarten's Stock Forecasts
AnalystsDavid Nierengarten
Sectors:
Industries:
Analyst Ranking
Top 6%
#283 out of 5290 analysts
Average Return
+12.85%
Win Rate
49%124 out of 255
Risk vs Reward
Poor
Good
David Nierengarten's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Chimerix IncCMRX | +870.45% | $0.88 | $8.54 | 2024-11-17 - 2025-04-17 | Buy |
Anaptysbio IncANAB | +405.93% | $23.10 | $116.87 | 2017-03-08 - 2018-03-09 | Buy |
Fusion Pharmaceuticals IncFUSN | +382.46% | $4.39 | $21.18 | 2023-06-27 - 2024-03-19 | Buy |
G1 Therapeutics IncGTHX | +352.53% | $1.58 | $7.15 | 2023-10-29 - 2024-09-17 | Buy |
Beam Therapeutics IncBEAM | +300.96% | $23.02 | $92.30 | 2020-03-01 - 2021-03-02 | Buy |
David Nierengarten Analyst Color
Get additional color on David Nierengarten's coverage of popular stocks
David Nierengarten's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Argenx SeARGX | 25 | Buy | $1,000.00 | +18.73% | Reiterates | a day ago |
Odyssey Therapeutics IncODTX | 1 | Buy | $30.00 | +76.47% | Initiates Coverage On | 3 days ago |
Abivax SaABVX | 2 | Hold | $90.00 | -14.23% | Upgrades | 3 days ago |
Cogent Biosciences IncCOGT | 6 | Buy | $55.00 | +67.73% | Reiterates | 7 days ago |
Nuvalent IncNUVL | 8 | Buy | $125.00 | +32.95% | Reiterates | 8 days ago |
Damora Therapeutics IncDMRA | 1 | Buy | $35.00 | +56.88% | Initiates Coverage On | 8 days ago |
Apogee Therapeutics IncAPGE | 5 | Buy | $135.00 | +48.51% | Maintains | 9 days ago |
Hemab Therapeutics Holdings IncCOAG | 1 | Buy | $42.00 | +65.29% | Initiates Coverage On | 10 days ago |
Sutro Biopharma IncSTRO | 8 | Buy | $60.00 | +109.21% | Upgrades | 21 days ago |
Intellia Therapeutics IncNTLA | 9 | Hold | $12.00 | -18.64% | Reiterates | 24 days ago |
Shattuck Labs IncSTTK | 3 | Buy | $11.00 | +129.17% | Maintains | a month ago |
Nuvation Bio IncNUVB | 16 | Buy | $11.00 | +112.77% | Reiterates | a month ago |
Perspective Therapeutics IncCATX | 8 | Buy | $11.00 | +238.46% | Reiterates | a month ago |
Kiniksa Pharmaceuticals International PLCKNSA | 8 | Buy | $59.00 | +19.85% | Maintains | a month ago |
Novocure LtdNVCR | 7 | Hold | $18.00 | +0.06% | Reiterates | 2 months ago |
Fennec Pharmaceuticals IncFENC | 4 | Buy | $13.00 | +41.92% | Reiterates | 2 months ago |
Spyre Therapeutics IncSYRE | 2 | Buy | $80.00 | +1.94% | Maintains | 2 months ago |
Telix Pharmaceuticals LtdTLX | 5 | Buy | $22.00 | +130.61% | Reiterates | 2 months ago |
Oric Pharmaceuticals IncORIC | 11 | Buy | $17.00 | +111.97% | Maintains | 2 months ago |
Scholar Rock Holding CorpSRRK | 8 | Buy | $58.00 | +27.95% | Maintains | 2 months ago |
Bicara Therapeutics IncBCAX | 4 | Buy | $30.00 | +46.99% | Reiterates | 2 months ago |
Tscan Therapeutics IncTCRX | 5 | Buy | $5.00 | +390.20% | Maintains | 3 months ago |
Beam Therapeutics IncBEAM | 4 | Buy | $65.00 | +97.93% | Maintains | 3 months ago |
Disc Medicine IncIRON | 5 | Buy | $88.00 | +23.75% | Maintains | 4 months ago |
Immunome IncIMNM | 7 | Buy | $31.00 | +57.52% | Reiterates | 5 months ago |
Generation Bio CoGBIO | 10 | Buy | $5.50 | +3.00% | Upgrades | 6 months ago |
Bridgebio Oncology Therapeutics IncBBOT | 2 | Buy | $25.00 | +203.77% | Reiterates | 6 months ago |
Fate Therapeutics IncFATE | 14 | Buy | $7.00 | +216.74% | Upgrades | 7 months ago |
Xencor IncXNCR | 8 | Buy | $26.00 | +116.49% | Reiterates | 9 months ago |
Imagenebio IncIMA | 5 | Hold | $276.00 | +4,750.62% | Maintains | 10 months ago |
Vor Biopharma IncVOR | 7 | Hold | $8.00 | -44.13% | Reiterates | a year ago |
Blueprint Medicines CorpBPMC | 5 | Hold | $129.00 | N/A | Downgrades | a year ago |
Iteos Therapeutics IncITOS | 3 | Hold | $12.00 | N/A | Downgrades | a year ago |
Springworks Therapeutics IncSWTX | 3 | Buy | $77.00 | N/A | Reiterates | a year ago |
Anaptysbio IncANAB | 11 | Buy | $40.00 | N/A | Maintains | a year ago |
Chimerix IncCMRX | 3 | Buy | $6.00 | N/A | Reiterates | 2 years ago |
Inozyme Pharma IncINZY | 6 | Buy | $15.00 | N/A | Reiterates | 2 years ago |
Y Mabs Therapeutics IncYMAB | 3 | Buy | $23.00 | N/A | Reiterates | 2 years ago |
Oruka Therapeutics IncORKA | 1 | Buy | $40.00 | N/A | Initiates Coverage On | 2 years ago |
Artiva Biotherapeutics IncARTV | 1 | Buy | $18.00 | N/A | Initiates Coverage On | 2 years ago |
2seventy Bio IncTSVT | 8 | Hold | $5.00 | N/A | Reiterates | 2 years ago |
Prime Medicine IncPRME | 3 | Buy | $12.00 | N/A | Reiterates | 2 years ago |
Fusion Pharmaceuticals IncFUSN | 4 | Hold | $24.00 | N/A | Downgrades | 2 years ago |
Bluebird Bio IncBLUE | 1 | Hold | $33.60 | N/A | Maintains | 2 years ago |
Mersana Therapeutics IncMRSN | 2 | Buy | $175.00 | N/A | Upgrades | 2 years ago |
G1 Therapeutics IncGTHX | 6 | Buy | $4.00 | N/A | Maintains | 2 years ago |
Kinnate Biopharma IncKNTE | 4 | Hold | $2.00 | N/A | Reiterates | 2 years ago |
Maxeon Solar Technologies LtdMAXNQ | 1 | Hold | $500.00 | N/A | Maintains | 2 years ago |
Freeline Therapeutics Holdings PLCFRLN | 2 | Hold | $5.00 | N/A | Downgrades | 3 years ago |
Karyopharm Therapeutics IncKPTI | 6 | Hold | $60.00 | N/A | Maintains | 3 years ago |
Theseus Pharmaceuticals IncTHRX | 2 | Buy | $7.00 | N/A | Maintains | 3 years ago |
Tectonic Therapeutic IncTECX | 1 | Hold | $24.00 | N/A | Downgrades | 3 years ago |
Iveric Bio IncISEE | 3 | Hold | $40.00 | N/A | Downgrades | 3 years ago |
Applied Genetic Technologies CorpAGTC | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Epizyme IncEPZM | 1 | Hold | N/A | N/A | Downgrades | 4 years ago |
Turning Point Therapeutics IncTPTX | 1 | Hold | $76.00 | N/A | Downgrades | 4 years ago |
Codiak Biosciences IncCDAKQ | 1 | Buy | $24.00 | N/A | Maintains | 4 years ago |
Tcr2 Therapeutics IncTCRR | 1 | Hold | $11.00 | N/A | Downgrades | 5 years ago |
Myokardia IncMYOK | 1 | Hold | $225.00 | N/A | Downgrades | 6 years ago |
Stemline Therapeutics IncSTML | 3 | Hold | $12.50 | N/A | Downgrades | 6 years ago |
Syros Pharmaceuticals IncSYRS | 3 | Hold | $90.00 | N/A | Downgrades | 6 years ago |
Tesaro IncTSRO | 3 | Hold | $75.00 | N/A | Downgrades | 8 years ago |
Spark Therapeutics IncONCE | 2 | Hold | $40.00 | N/A | Upgrades | 8 years ago |
Ultragenyx Pharmaceutical IncRARE | 6 | Buy | $88.00 | N/A | Maintains | 8 years ago |
Audentes Therapeutics IncBOLD1 | 1 | Buy | $52.00 | N/A | Maintains | 8 years ago |
Endocyte IncECYT | 3 | Buy | $21.00 | N/A | Maintains | 8 years ago |
Voyager Therapeutics IncVYGR | 2 | Buy | N/A | N/A | Upgrades | 8 years ago |
Prothena Corp Public Ltd CoPRTA | 1 | Hold | N/A | N/A | Downgrades | 9 years ago |
Kite Pharma IncKITE | 2 | Hold | N/A | N/A | Upgrades | 9 years ago |
Juno Therapeutics IncJUNO | 1 | Buy | N/A | N/A | Upgrades | 9 years ago |
Clementia Pharmaceuticals IncCMTA | 1 | Buy | $26.00 | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.